Indoloquinoline Ligands Favor Intercalation at Quadruplex-Duplex Interfaces.

Area of Science:

• Medicinal Chemistry
• Structural Biology
• Biophysics

Background:

• Quadruplex-duplex (Q-D) junctions are emerging as significant targets in medicine and technology.
• Understanding ligand interactions with these complex DNA structures is crucial for therapeutic development.

Purpose of the Study:

• To design and characterize a novel Q-D hybrid structure.
• To investigate the binding mechanism and affinity of the indoloquinoline ligand SYUIQ-5 to this Q-D target.
• To elucidate the structural basis for ligand-Q-D junction recognition.

Main Methods:

• Nuclear Magnetic Resonance (NMR) spectroscopy for structural analysis.
• Isothermal Titration Calorimetry (ITC) for determining binding thermodynamics.
• Comparative binding studies with related ligands.

Main Results:

• SYUIQ-5 demonstrated high-affinity binding (K_a ~10⁷ M^-1, ΔH° ~ -14 kcal/mol) at the Q-D interface.
• Structural analysis revealed SYUIQ-5 intercalation between the 3'-outer tetrad and a CG base pair, optimizing π-π stacking and electrostatic interactions.
• The SYUIQ-5 sidechain interacts with the duplex minor groove, potentially enhancing affinity and stabilizing the ligand's core.

Conclusions:

• The indoloquinoline ring system's geometry and charge distribution are key for Q-D junction selectivity.
• The SYUIQ-5 sidechain contributes to binding affinity and orientation.
• These findings provide a foundation for designing novel ligands targeting Q-D interfaces for medicinal applications.